Study to Assess the Efficacy and Safety of Ryanodex as Adjuvant Treatment in Subjects With EHS
Clinical trial NCT03600376 · COMPLETED
Trial details
- NCT number
- NCT03600376
- Sponsor
- Eagle Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-19
- Primary completion
- 2019-08-14
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.